Cite

HARVARD Citation

    Kim, D. et al. (2016). Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations. Cancer biology & therapy. 17 (1), pp. 65-78. [Online]. 
  
Back to record